These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6376194)
1. A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation. Grönroos M; Nieminen U; Kauppila A; Kauppila O; Saksela E; Väyrynen M Eur J Obstet Gynecol Reprod Biol; 1984 Apr; 17(1):33-42. PubMed ID: 6376194 [TBL] [Abstract][Full Text] [Related]
2. A randomized study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinoma. Aabo K; Hald I; Hørbov S; Dombernowsky P; Hansen HH; Sørensen HM; Lundvall F; Nielsen NC; Sørensen BL Eur J Cancer Clin Oncol; 1985 Apr; 21(4):475-81. PubMed ID: 3891362 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study. Randall ME; Barrett RJ; Spirtos NM; Chalas E; Homesley HD; Lentz SL; Hanna M Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):139-47. PubMed ID: 12118543 [TBL] [Abstract][Full Text] [Related]
4. [Tolerance and role of irradiation in the treatment of epithelial cancer of the ovary]. Quétin P; Marchal C; Hoffstetter S; Cutuli B; Beckendorf V; Lapeyre M; Peiffert D; Bey P Cancer Radiother; 1998; 2(4):366-74. PubMed ID: 9755750 [TBL] [Abstract][Full Text] [Related]
5. [Postoperative radio- and/or chemotherapy in ovarian stage III cancers. Results of a prospective randomized study]. Richter P; Sarembe B; Lotze W Zentralbl Gynakol; 1985; 107(4):237-44. PubMed ID: 3885634 [TBL] [Abstract][Full Text] [Related]
6. Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Sell A; Bertelsen K; Andersen JE; Strøyer I; Panduro J Gynecol Oncol; 1990 Jun; 37(3):367-73. PubMed ID: 2351321 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of 63 advanced ovarian carcinomas]. Liu LY; Hong WJ; Hou YJ; Yao ZH; Wu AR; Li L Zhonghua Zhong Liu Za Zhi; 1987 Sep; 9(5):375-8. PubMed ID: 3452529 [TBL] [Abstract][Full Text] [Related]
8. Intravenous treosulfan versus intravenous treosulfan plus cisplatinum in advanced ovarian carcinoma. Masding J; Sarkar TK; White WF; Barley VL; Chawla SL; Boesen E; Rostom AY; Menday AP Br J Obstet Gynaecol; 1990 Apr; 97(4):342-51. PubMed ID: 2187525 [TBL] [Abstract][Full Text] [Related]
9. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes. Firat S; Murray K; Erickson B Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):201-7. PubMed ID: 12909234 [TBL] [Abstract][Full Text] [Related]
10. Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer. Chiara S; Orsatti M; Franzone P; Scarpati D; Bruzzone M; Repetto L; Vitale V; Conte PF; Rosso R Clin Oncol (R Coll Radiol); 1991 Nov; 3(6):340-4. PubMed ID: 1742234 [TBL] [Abstract][Full Text] [Related]
11. Advanced stage III ovarian carcinoma. Prospective randomized trials comparing radiotherapy and chemotherapy. Sigurdsson K Acta Obstet Gynecol Scand; 1986; 65(1):69-74. PubMed ID: 3521187 [TBL] [Abstract][Full Text] [Related]
12. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study. Kies MS; Mira JG; Crowley JJ; Chen TT; Pazdur R; Grozea PN; Rivkin SE; Coltman CA; Ward JH; Livingston RB J Clin Oncol; 1987 Apr; 5(4):592-600. PubMed ID: 3031226 [TBL] [Abstract][Full Text] [Related]
13. [Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients]. Salzer H; Gitsch E; Dittrich C; Sevelda P; Karrer K; Schemper M; Stempel-Smekal G; Langer M; Wagner G; Rainer H Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):761-8. PubMed ID: 3908214 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma. Fuks Z; Rizel S; Biran S J Clin Oncol; 1988 Mar; 6(3):509-16. PubMed ID: 3127551 [TBL] [Abstract][Full Text] [Related]
15. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide. Gershenson DM; Copeland LJ; Kavanagh JJ; Cangir A; Del Junco G; Saul PB; Stringer CA; Freedman RS; Edwards CL; Wharton JT Cancer; 1985 Dec; 56(12):2756-61. PubMed ID: 2996746 [TBL] [Abstract][Full Text] [Related]
16. Advances in chemotherapy for gynecologic cancer. Smith JP; Rutledge F Cancer; 1975 Aug; 36(2):669-74. PubMed ID: 1157027 [TBL] [Abstract][Full Text] [Related]
17. Results of post-operative abdomino-pelvic radiotherapy in intermediate- and high-risk epithelial ovarian carcinoma. Mosalaei A; Kazerooni T Eur J Cancer Care (Engl); 2008 Jul; 17(4):371-6. PubMed ID: 18537815 [TBL] [Abstract][Full Text] [Related]
18. Sequential cisplatin/cyclophosphamide chemotherapy and abdominopelvic radiotherapy in the management of advanced ovarian cancer. Green JA; Warenius HM; Errington RD; Myint S; Spearing G; Slater AJ Br J Cancer; 1988 Nov; 58(5):635-9. PubMed ID: 3219276 [TBL] [Abstract][Full Text] [Related]
19. Advanced epithelial ovarian cancer: salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy. Schray MF; Martinez A; Howes AE; Podratz KC; Ballon SC; Malkasian GD; Sikic BI J Clin Oncol; 1988 Sep; 6(9):1433-9. PubMed ID: 3418375 [TBL] [Abstract][Full Text] [Related]
20. Multimodal approach to the treatment of stage III ovarian carcinoma: preliminary report of a pilot study and critical review. Paule B; Frydman R; Chasseray JM Biomed Pharmacother; 1985; 39(5):241-5. PubMed ID: 4084658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]